The botulinum toxin brand was launched in June 2020. Korea Letibao is the second botulinum toxin brand listed this year and the fourth botulinum toxin brand approved in China.

In South Korea, Letibao's market share exceeds 40%, ranking first.

Judging from the curative effect, Letibao has the advantages of short course of treatment, quick response and short repair cycle, and does not affect daily work and life.

Compared with other domestic botulinum toxin products, Lotebao has the characteristics of high quality, high efficiency and high safety. .